Diabetes patient registration started in January

No survey, statistics or initiative has been taken so far as to diabetes patients in Bangladesh. Digital registration will start from January this year to create the database on this issue, which is the first time in the country.

Today, at around 12 noon, at the MoU at a compromise sign at the Dhaka Club in the capital, Ramna. The Bangladesh Diabetes Association of Bangladesh (Badas) will complete the complete digital registration process. Novo Norodisc, a Danish-based international pharmaceutical company, will assist in this.

On behalf of Badas President AK Azad Khan and Novo Nordisk, senior Vice President Fredrick Kier signed a memorandum.

AK Azad Khan said, "There is no exact number of diabetic patients in Bangladesh or any such survey. Through this registration across the country, I think that a correct image can be found, not just the patient's number. '

From the program, Novo Nordisk has been working for the last 90 years under the control of world-wide diabetes. As a result of the digital registration, the quality of diabetes patient can be ensured by analyzing and analyzing information-data analysis of registered diabetes patients.

The president of the company, Frederick Kier, said in the program that due to digital registration in Bangladesh, the proper picture of the health of the patients will be highlighted. This can give full attention to the problems; Which will help to combat any type of risk.

With the participation of Novo NORDISK SKF Firm, insulin is being made in Bangladesh since 2012. This Insulin Transcom Distribution is supplied nationwide. General Manager of Transcom Distribution Asaduzzaman was present on the occasion.

Badas Director General Saifuddin, Managing Director of Novo Nadisk, Ananda Sethi, Head of Marketing Mohammad Saiful, addressed Novo Nordisk Bangladesh.